Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death
- PMID: 19001090
- PMCID: PMC2612510
- DOI: 10.1128/MCB.01661-08
Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death
Abstract
The intracellular signaling mechanisms underlying the pathogenesis of cardiac diseases are not fully understood. We report here that selective deletion of Shp2, an SH2-containing cytoplasmic tyrosine phosphatase, in striated muscle results in severe dilated cardiomyopathy in mice, leading to heart failure and premature mortality. Development of cardiomyopathy in this mouse model is coupled with insulin resistance, glucose intolerance, and impaired glucose uptake in striated muscle cells. Shp2 deficiency leads to upregulation of leukemia inhibitory factor-stimulated phosphatidylinositol 3-kinase/Akt, Erk5, and Stat3 pathways in cardiomyocytes. Insulin resistance and impaired glucose uptake in Shp2-deficient mice are at least in part due to impaired protein kinase C-zeta/lambda and AMP-kinase activities in striated muscle. Thus, we have generated a mouse line modeling human patients suffering from cardiomyopathy and insulin resistance. This study reinforces a concept that a compound disease with multiple cardiovascular and metabolic disturbances can be caused by a defect in a single molecule such as Shp2, which modulates multiple signaling pathways initiated by cytokines and hormones.
Figures







Similar articles
-
Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways.Circulation. 2008 Mar 18;117(11):1423-35. doi: 10.1161/CIRCULATIONAHA.107.728865. Epub 2008 Mar 3. Circulation. 2008. PMID: 18316486 Free PMC article.
-
Altered glucose homeostasis in mice with liver-specific deletion of Src homology phosphatase 2.J Biol Chem. 2010 Dec 17;285(51):39750-8. doi: 10.1074/jbc.M110.153734. Epub 2010 Sep 14. J Biol Chem. 2010. PMID: 20841350 Free PMC article.
-
Adipose-specific deletion of Src homology phosphatase 2 does not significantly alter systemic glucose homeostasis.Metabolism. 2011 Aug;60(8):1193-201. doi: 10.1016/j.metabol.2011.01.004. Epub 2011 Feb 25. Metabolism. 2011. PMID: 21353259 Free PMC article.
-
Role of oxidative stress in impaired insulin signaling associated with exercise-induced muscle damage.Free Radic Biol Med. 2013 Dec;65:1265-1272. doi: 10.1016/j.freeradbiomed.2013.09.014. Epub 2013 Sep 27. Free Radic Biol Med. 2013. PMID: 24075894 Review.
-
The role of the protein tyrosine phosphatase SHP2 in cardiac development and disease.Semin Cell Dev Biol. 2015 Jan;37:73-81. doi: 10.1016/j.semcdb.2014.09.013. Epub 2014 Sep 22. Semin Cell Dev Biol. 2015. PMID: 25256404 Free PMC article. Review.
Cited by
-
Loss of EGF receptor polarity enables homeostatic imbalance in epithelial-cell models.Mol Biol Cell. 2023 Nov 1;34(12):ar116. doi: 10.1091/mbc.E23-04-0133. Epub 2023 Aug 30. Mol Biol Cell. 2023. PMID: 37647145 Free PMC article.
-
Hepatic Src homology phosphatase 2 regulates energy balance in mice.Endocrinology. 2012 Jul;153(7):3158-69. doi: 10.1210/en.2012-1406. Epub 2012 May 22. Endocrinology. 2012. PMID: 22619361 Free PMC article.
-
The contribution of natural selection to present-day susceptibility to chronic inflammatory and autoimmune disease.Curr Opin Immunol. 2014 Dec;31:66-78. doi: 10.1016/j.coi.2014.09.008. Epub 2014 Oct 22. Curr Opin Immunol. 2014. PMID: 25458997 Free PMC article. Review.
-
Metabolic regulation by protein tyrosine phosphatases.J Biomed Res. 2014 May;28(3):157-68. doi: 10.7555/JBR.28.20140012. Epub 2014 Feb 28. J Biomed Res. 2014. PMID: 25013399 Free PMC article.
-
A tyrosine phosphatase SHP2 gain-of-function mutation enhances malignancy of breast carcinoma.Oncotarget. 2016 Feb 2;7(5):5664-76. doi: 10.18632/oncotarget.6561. Oncotarget. 2016. PMID: 26673822 Free PMC article.
References
-
- Akazawa, H., and I. Komuro. 2003. Roles of cardiac transcription factors in cardiac hypertrophy. Circ. Res. 921079-1088. - PubMed
-
- Bruning, J. C., M. D. Michael, J. N. Winnay, T. Hayashi, D. Horsch, D. Accili, L. J. Goodyear, and C. R. Kahn. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2559-569. - PubMed
-
- Camper-Kirby, D., S. Welch, A. Walker, I. Shiraishi, K. D. Setchell, E. Schaefer, J. Kajstura, P. Anversa, and M. A. Sussman. 2001. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ. Res. 881020-1027. - PubMed
-
- Carroll, R., A. N. Carley, J. R. Dyck, and D. L. Severson. 2005. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts. Am. J. Physiol. Endocrinol. Metab. 288E900-E906. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous